BIO VIEW LTD 

$0.9666
0
+$0.00+0% Tuesday 20:00

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

股息

0%股息殖利率
Apr 17
$0.55
10年成長
不適用
5年成長
不適用
3年成長
不適用
1年成長
不適用

財報

30Sep預期
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
0
0.02
0.04
預期EPS
不適用
實際EPS
0.0248

財務

0.99%利潤率
有盈利
2018
2019
2020
2021
2022
2023
9.52M營收
94,644.32淨利

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Bio-View Ltd, founded in 2000 and headquartered in Rehovot, Israel, is a developer, manufacturer, and global distributor of advanced automated cell imaging and analysis systems. These sophisticated solutions are utilized by clinical and research laboratories worldwide, specifically in the fields of cytology, cytogenetics, and pathology. The company's extensive product lineup includes: Accord: A semi-automated fluorescent imaging and analysis workbench microscope station. Accord Plus: An automatic fluorescent imaging system capable of real-time scanning, analysis, and sorting of diverse FISH (Fluorescence In Situ Hybridization) samples. Allegro Plus: Another automatic fluorescent imaging system engineered to pinpoint various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. DUET-3: An imaging and analysis platform featuring an automated barcode reader, which streamlines the processing of multiple test types within a single scan batch. DeNovo: An automated scanning system dedicated to the precise detection, analysis, and characterization of circulating tumor cells found in peripheral blood. Solo Workstation & Solo Touch Workstation: These are offline and standalone workstations, respectively, providing advanced tools for reviewing and analyzing test results remotely from the microscope. SoloWeb: A comprehensive web-based solution that enables remote analysis, reporting, and expert consultation on cases scanned using Bio-View's systems. Furthermore, Bio-View Ltd has established a strategic partnership with ANGLE plc to jointly develop a liquid biopsy circulating tumor cell HER2 assay, specifically targeting breast cancer.
Show more...
執行長
Daniel Klain
員工
30
國家
以色列

上市

0 Comments

分享你的想法

FAQ

BIO VIEW LTD 今天的股價是多少?
BIVWF 目前價格為 $0.97 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 BIO VIEW LTD 股價表現。
BIO VIEW LTD 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 PINK 交易所,BIO VIEW LTD 的股票以代號 BIVWF 進行交易。
BIO VIEW LTD 上一季度的財報如何?
BIVWF 上一季度的財報為每股 0.02 USD,預估為 不適用 USD,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 USD。
BIO VIEW LTD 去年的營收是多少?
BIO VIEW LTD 去年的營收為 9.52MUSD。
BIO VIEW LTD 去年的淨利是多少?
BIVWF 去年的淨收益為 94,644.32USD。
BIO VIEW LTD 會發放股息嗎?
是的,BIVWF 的股息每 年度 發放一次。每股最新股息為 0.55 USD。截至今日,股息殖利率(FWD)% 為 0%。
BIO VIEW LTD 有多少名員工?
截至 August 27, 2026,公司共有 30 名員工。
BIO VIEW LTD 位於哪個產業?
BIO VIEW LTD從事於Health & Wellness產業。
BIO VIEW LTD 何時完成拆股?
BIO VIEW LTD 上次拆股發生於 December 24, 2023,比例為 1:10。
BIO VIEW LTD 的總部在哪裡?
BIO VIEW LTD 的總部位於 以色列 的 Rehovot。